Pilocarpine Hydrochloride



Indications and Reactions:

Role Indications Reactions
Primary
Glaucoma 22.7%
Sjogren's Syndrome 22.7%
Dry Mouth 18.2%
Cataract 4.5%
Drug Use For Unknown Indication 4.5%
Dry Eye 4.5%
Gastritis Prophylaxis 4.5%
Insomnia 4.5%
Postoperative Care 4.5%
Product Used For Unknown Indication 4.5%
Stomatitis 4.5%
Drug Ineffective 11.8%
Vertigo 11.8%
Chest Pain 5.9%
Death 5.9%
Hypersomnia 5.9%
Liver Function Test Abnormal 5.9%
Malaise 5.9%
Pallor 5.9%
Pupillary Disorder 5.9%
Sick Sinus Syndrome 5.9%
Tremor 5.9%
Urinary Retention 5.9%
Urticaria 5.9%
Vertigo Cns Origin 5.9%
Visual Acuity Reduced 5.9%
Secondary
Product Used For Unknown Indication 20.3%
Glaucoma 17.7%
Drug Use For Unknown Indication 10.1%
Intraocular Pressure Increased 10.1%
Angle Closure Glaucoma 8.9%
Ocular Hypertension 6.3%
Ill-defined Disorder 5.1%
Chronic Obstructive Pulmonary Disease 2.5%
Eye Pain 2.5%
Neuralgia 2.5%
Sleep Disorder 2.5%
Visual Acuity Reduced 2.5%
Anorexia 1.3%
Blood Pressure 1.3%
Depression 1.3%
Dry Mouth 1.3%
Insomnia 1.3%
Macular Oedema 1.3%
Migraine 1.3%
Visual Acuity Reduced 15.0%
Haemorrhage 10.0%
Rectal Haemorrhage 10.0%
Therapeutic Agent Toxicity 10.0%
Transaminases Increased 10.0%
Headache 5.0%
Intraocular Pressure Increased 5.0%
Ocular Hypertension 5.0%
Orthostatic Hypotension 5.0%
Speech Disorder 5.0%
Uveitis 5.0%
Vision Blurred 5.0%
Visual Impairment 5.0%
Vitreous Floaters 5.0%
Concomitant
Drug Use For Unknown Indication 39.1%
Product Used For Unknown Indication 23.1%
Rheumatoid Arthritis 12.5%
Glaucoma 5.7%
Breast Cancer 2.5%
Depression 2.4%
Pain 2.1%
Hypertension 1.7%
Acute Myeloid Leukaemia 1.4%
Sjogren's Syndrome 1.3%
Vitamin Supplementation 1.1%
Osteoarthritis 1.0%
Pancreatic Neuroendocrine Tumour 1.0%
Breast Cancer Metastatic 0.8%
Dry Mouth 0.8%
Renal Cell Carcinoma 0.8%
Cardiac Failure Congestive 0.7%
Fibromyalgia 0.7%
Metastatic Gastric Cancer 0.7%
Dental Care 0.6%
Vomiting 13.9%
Weight Decreased 8.9%
Generalised Oedema 7.6%
Spinal Osteoarthritis 7.6%
Vision Blurred 6.3%
Malaise 5.1%
Metabolic Encephalopathy 5.1%
Peritonitis 5.1%
Convulsion 3.8%
Intraocular Pressure Increased 3.8%
Scleroderma 3.8%
Sepsis 3.8%
Sudden Death 3.8%
Tachycardia 3.8%
Unevaluable Event 3.8%
Weight Increased 3.8%
Cerebrovascular Accident 2.5%
Disease Progression 2.5%
Drug Ineffective 2.5%
Gastrointestinal Haemorrhage 2.5%